Abstract
Bioassay-directed fractionation of extracts of a Synoicum n. sp. ascidian from New Zealand led to the isolation of the principal anti-inflammatory component, which was identified by spectroscopic methods as a new member of the rubrolide family, rubrolide O (1), existing as a mixture of E/Z isomers.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Anti-Inflammatory Agents* / chemistry
-
Anti-Inflammatory Agents* / isolation & purification
-
Anti-Inflammatory Agents* / pharmacology
-
Furans* / chemistry
-
Furans* / isolation & purification
-
Furans* / pharmacology
-
Humans
-
Hydrocarbons, Halogenated* / chemistry
-
Hydrocarbons, Halogenated* / isolation & purification
-
Hydrocarbons, Halogenated* / pharmacology
-
Molecular Structure
-
Neutrophils / metabolism
-
New Zealand
-
Stereoisomerism
-
Urochordata / chemistry*
Substances
-
Anti-Inflammatory Agents
-
Furans
-
Hydrocarbons, Halogenated
-
rubrolide O